← Research index  ·  Disorder page  ·  Source YAML

Cross-provider research synthesis

Acute Hypotension

MONDO:0005174 Curated 2026-07-04T00:00:00Z 9 harmonized findings
falcon · 43 citations openscientist · 66 citations
Concordant asserts the finding Partial supports a weaker/qualified form Contradictory conflicts with it Silent does not address it

Harmonized findings

Acute hypotension is not a single disease but a final common hemodynamic phenotype/syndrome arising from four fundamental mechanisms — distributive, cardiogenic, hypovolemic, and obstructive — each with distinct causal pathways.

UNANIMOUS INTEGRATED
pathophysiology
ProviderStanceScoreEvidence
falcon CONCORDANT 90% Acute hypotension is best handled as a **final common hemodynamic phenotype** with multiple etiologies.
Falcon frames acute hypotension as a final common hemodynamic phenotype and lays out the same bedside cardiogenic/hypovolemic/obstructive/vasoplegic (distributive) shock taxonomy.
DOI:10.31744/einstein_journal/2024rw0775
openscientist CONCORDANT 95% It is not a single disease but rather a final common pathway arising from four fundamental hemodynamic mechanisms: distributive (septic, anaphylactic, neurogenic), cardiogenic (myocardial infarction, heart failure, arrhythmia), hypovolemic (hemorrhage, dehydration), and obstructive (pulmonary embolism, cardiac tamponade).
OpenScientist gives the identical four-mechanism framing with worked examples of each category.

There is no universally accepted single definition of acute hypotension; MAP <65 mmHg (or SBP <90 mmHg) is the most frequently used clinical threshold, with definitional heterogeneity across settings.

UNANIMOUS INTEGRATED
diagnosis
ProviderStanceScoreEvidence
falcon CONCORDANT 92% ICU hypotension remains defined in many ways (140 definitions), yet MAP <65 mmHg is still the dominant operational threshold; observational associations are consistent and severity-dependent.
Falcon emphasizes the unresolved harmonization (140 distinct ICU definitions) with MAP <65 mmHg as the dominant operational threshold.
DOI:10.1007/s00134-023-07304-4
openscientist CONCORDANT 92% While no universally accepted single definition exists, the most widely used clinical threshold is a MAP <65 mmHg or a systolic blood pressure (SBP) <90 mmHg.
OpenScientist agrees no single accepted definition exists and names MAP <65 / SBP <90 mmHg as the most widely used thresholds.

Acute/perioperative hypotension is an independent, severity- and duration-dependent predictor of adverse outcomes including mortality, acute kidney injury, and myocardial injury.

UNANIMOUS INTEGRATED
prognosis
ProviderStanceScoreEvidence
falcon CONCORDANT 80% hypotension associated with mortality OR 1.45 (95% CI 1.12–1.88); majority of studies also linked greater hypotension severity with AKI risk
Falcon reports the Schuurmans ICU meta-analysis (mortality OR 1.45) and the severity-dependent AKI association — same direction as OpenScientist but a lower effect size drawn from a general ICU cohort rather than a postoperative cohort.
DOI:10.1007/s00134-023-07304-4
openscientist CONCORDANT 85% a meta-analysis of 262,435 patients found associations with mortality (OR 2.51), myocardial injury (OR 2.52), acute kidney injury (OR 1.72), and stroke (OR 1.82).
OpenScientist reports a large postoperative-hypotension meta-analysis with higher effect sizes (mortality OR 2.51) plus myocardial injury, AKI, and stroke. Concordant on direction; the numeric magnitudes differ because the populations differ (POH vs general ICU).

Norepinephrine is the first-line vasopressor for acute hypotension requiring vasopressor support, targeting a MAP of ~65 mmHg, per Surviving Sepsis Campaign guidance.

UNANIMOUS INTEGRATED
treatment
ProviderStanceScoreEvidence
falcon CONCORDANT 90% an early resuscitation approach with **MAP target ~65 mmHg** and **norepinephrine as first-line vasopressor**
Falcon states the MAP ~65 mmHg target and norepinephrine-first approach for sepsis-associated acute hypotension.
DOI:10.1097/aln.0000000000004958
openscientist CONCORDANT 95% centers on norepinephrine as the first-line vasopressor (used by 96.5% of ICU practitioners) targeting MAP ≥65 mmHg
OpenScientist gives the same first-line norepinephrine / MAP >=65 mmHg target and quantifies practitioner adoption (96.5%).
PMID:34895959

Early/preemptive norepinephrine (including prophylactic or peripheral initiation) improves short-term shock control and reduces the incidence of hypotension.

UNANIMOUS LEAD
treatment
ProviderStanceScoreEvidence
falcon CONCORDANT 80% early norepinephrine improves short-term shock control and may reduce cardiopulmonary complications, aligning with algorithmic care maps
Falcon summarizes the CENSER-based evidence that early norepinephrine improves short-term shock control and may reduce cardiopulmonary complications.
DOI:10.1097/aln.0000000000004958
openscientist CONCORDANT 75% demonstrated a significantly lower incidence of post-induction hypotension (10% vs. 45%)
OpenScientist reports prophylactic norepinephrine cutting post-induction hypotension from 45% to 10% and cites the VASOSHOCK early-peripheral-vasopressor trial — concordant on the early/preemptive-vasopressor direction via a different study.

Acute hypotension is not a monogenic/Mendelian disorder; genetic contributions are modulatory (pharmacogenomic and receptor polymorphisms), and the role of genetics/epigenetics in sepsis remains an open research gap.

UNANIMOUS INTEGRATED
genetic_factor
ProviderStanceScoreEvidence
falcon CONCORDANT 80% Acute hypotension is not typically monogenic.
Falcon states acute hypotension is not typically monogenic and highlights that Surviving Sepsis Campaign priorities flag genetics/epigenetics as an underexplored but important domain in sepsis.
DOI:10.1097/ccm.0000000000006135
openscientist CONCORDANT 85% Acute hypotension is not a Mendelian disorder. It follows a multifactorial, polygenic susceptibility model with strong environmental triggers.
OpenScientist agrees it is not Mendelian, describing a multifactorial polygenic susceptibility model with modulatory genetic contributions (NOS2, ACE, adrenergic-receptor polymorphisms).

iNOS-mediated overproduction of nitric oxide is the central molecular mechanism of septic vasodilation and catecholamine-refractory hypotension.

SINGLE LEAD
pathophysiologygene_function
ProviderStanceScoreEvidence
openscientist CONCORDANT 95% the central molecular mechanism involves inducible nitric oxide synthase (iNOS)-mediated overproduction of nitric oxide, causing profound vasodilation and vascular hyporeactivity to catecholamines.
OpenScientist develops the full LPS -> TLR-4 -> NF-kB -> iNOS/NOS2 -> NO -> cGMP -> vasodilation causal chain with rodent iNOS-inhibitor evidence.
PMID:7541282
falcon SILENT —
Falcon lists broad sepsis mechanisms (microvascular, immune/autonomic dysfunction, apoptosis, mitochondrial damage, coagulation) but never names the iNOS/NO pathway as the central mechanism of septic vasodilation.

In hemorrhagic shock, a deliberately lower blood-pressure resuscitation strategy (permissive hypotension / low-dose norepinephrine before hypotensive resuscitation) reduces mortality versus conventional aggressive resuscitation.

MAJORITY LEAD
treatment
ProviderStanceScoreEvidence
openscientist CONCORDANT 85% Permissive hypotension was only associated with decreased mortality within hospital settings (6.3% vs 16.3%, P = .045)
OpenScientist reports the permissive-hypotension systematic review (in-hospital mortality 6.3% vs 16.3%) with concurrent reductions in ARDS, MOF, and DIC.
PMID:42030689
falcon PARTIAL 55% A 2024 randomized trial in severely traumatized hemorrhagic shock patients (inclusion MAP 65–75 mmHg) reported that early low-dose norepinephrine plus fluids reduced
Falcon supports the broader lower-BP hemorrhagic-resuscitation theme via a different intervention (early low-dose norepinephrine within a hypotensive MAP 65-75 target reducing mortality), not the permissive-hypotension systematic review itself — complementary, not contradictory.
DOI:10.35975/apic.v28i5.2560

Procedural and perioperative hypotension is highly common, with intraoperative and peri-intubation episodes affecting a large fraction of patients and predicting worse outcomes.

UNANIMOUS INTEGRATED
epidemiology
ProviderStanceScoreEvidence
falcon CONCORDANT 80% Review reports PIH incidence varies from 19% to 52% and is associated with acute myocardial infarction, renal failure, longer hospitalization, and poor overall outcomes
Falcon quantifies post-intubation hypotension incidence (19-52%) and its outcome associations across the critical-care literature.
DOI:10.36502/2024/asjbccr.6384
openscientist CONCORDANT 80% intraoperative hypotension (IOH) affecting 25–50% of surgical patients and intradialytic hypotension (IDH) complicating 10–12% of hemodialysis sessions
OpenScientist gives the parallel intraoperative-hypotension (25-50%) and intradialytic-hypotension (10-12%) frequencies, reinforcing that setting-specific acute hypotension is common.

Narrative

Overview

Both providers frame acute hypotension not as a single disease but as a final common hemodynamic phenotype — a syndrome of inadequate tissue perfusion arising from distributive, cardiogenic, hypovolemic, and obstructive mechanisms. Falcon (Edison Scientific Literature) is threshold- and setting-oriented, anchored in 2023-2024 ICU/perioperative/peri-intubation literature and the unresolved problem of defining hypotension. OpenScientist is comprehensive and mechanism-rich, adding a molecular pathophysiology layer, a full diagnostics/treatment/model-organism survey, and disease-coding identifiers.

Agreement

The reports converge strongly on the core clinical picture: the four-mechanism hemodynamic classification, the absence of a single accepted definition with MAP <65 mmHg as the dominant threshold, hypotension as an independent severity/duration-dependent predictor of mortality and organ injury, norepinephrine as the first-line vasopressor targeting MAP ~65 mmHg, the value of early/preemptive vasopressor initiation, the non-monogenic (modulatory) role of genetics, and the high frequency of procedural/perioperative hypotension.

Divergence

Divergence is coverage/emphasis, not conflict. OpenScientist uniquely develops the iNOS/NO molecular mechanism of septic vasodilation (with the paradoxically protective HO-1/CO arm), which Falcon does not name. On prognosis the two report different effect sizes (Falcon's ICU mortality OR 1.45 vs OpenScientist's postoperative OR 2.51) because they draw on different populations — a quantitative difference, not a contradiction. On hemorrhagic shock they support the same lower-BP resuscitation theme through different interventions (OpenScientist: permissive hypotension; Falcon: early low-dose norepinephrine within a hypotensive MAP 65-75 target).

Integration

Integrated into the disorder entry: the syndrome-level four-mechanism framing, the definitional heterogeneity and MAP <65 mmHg threshold, the outcome/ prognosis associations, first-line norepinephrine with a MAP ~65 mmHg target, the non-monogenic genetic characterization, and the epidemiologic prominence of intraoperative/peri-intubation hypotension.

Not integrated (leads)

Retained as research leads rather than promoted: the detailed iNOS/NO (and HO-1/CO) septic-vasodilation molecular cascade, the early/preemptive prophylactic-norepinephrine evidence, and the permissive-hypotension hemorrhagic-shock strategy — all well-sourced but pending fetch-reference verification of the underlying PMIDs/DOIs before promotion to curated mechanisms and treatments.

Cross-provider synthesis comparing falcon (Edison Scientific Literature, threshold/setting-focused, author-year citation keys) and openscientist (comprehensive, PMID-linked). No direct contradictions were found; divergence is coverage/recency and population-dependent effect sizes. best_matching_text values are verbatim excerpts from the two report files; per-provider citations are recorded but literature evidence: blocks were intentionally left unpopulated pending fetch-reference verification.